NEW YORK (GenomeWeb News) – Trovagene this week filed a shelf registration with the US Securities and Exchange Commission for the public offering of up to $150 million in securities from time to time.

A spokesperson for the San Diego-based molecular diagnostic firm said the filing is associated with a public offering that the company made in the spring of 2012 when it began trading its stock on the Nasdaq.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.

GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.

Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.

A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.